Tinda, Sayde A.
HRN: 23-64-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/03/2023
09/10/2023
IV
75mg
Q6
Anemia Etiology To Be Determined, Mumps
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes